Biopharmaceutical companies don’t have to stick to a single bioreactor design during scale-up. That’s according to Stefan Junne, PhD, an associate professor at Aalborg University. Junne ...

Trade bodies representing the European prescription and over-the-counter pharma sectors have issued ... that the patient can easily access the package leaflet for their medicine in their chosen ...

The European Parliament has voted through reforms to legislation regulating the pharma sector ... no getting away from the fact that the package reduces RDP for new medicines by six months.

(RTTNews) - Medicus Pharma Ltd (MDCX) announced that it has submitted a Phase 2 clinical trial design or SKNJCT-004 to the UAE Department of Health or DOH for its non-invasive treatment for Basal ...